Literature DB >> 8231086

Induction of diabetes mellitus in Syrian golden hamsters using stored equilibrium solutions of streptozotocin.

S P Povoski1, P J McCullough, W Zhou, R H Bell.   

Abstract

Streptozotocin (STZ), a compound composed of a mixture of alpha and beta anomers, is used experimentally for the chemical induction of diabetes mellitus in numerous animal species. It is routinely recommended that STZ be administered rapidly following dissolution because of its alleged instability in solution. In the present study, we examined the effect of varying the length of time from dissolution to administration on the ability of STZ to induce diabetes mellitus in male Syrian golden hamsters and examined STZ stability and state of equilibrium by high-pressure liquid chromatography. Effective diabetes induction was determined by monitoring plasma glucose concentrations 2 and 9 days after STZ treatment. Diabetes was successfully induced with solutions of STZ (50 mg/kg body weight given intraperitoneally on three consecutive days) used either immediately (24 degrees C), 2 hours (24 degrees C), or 5 to 7 days (6 degrees C) after dissolution in 0.1 M acetate buffer at pH 4.4 (storage temperature indicated in parentheses). Mean plasma glucose concentration was significantly higher in all STZ treatment groups at both time points when compared with acetate buffer-treated controls. There was no significant difference in plasma glucose concentration between STZ treatment groups. High-pressure liquid chromatography analysis demonstrated that the alpha- to beta-anomeric ratio of STZ had reached equilibrium in 84 minutes at 24 degrees C and by 26 hours at 6 degrees C following dissolution. Recovery of STZ was greater in solutions stored at 6 degrees C than at room temperature (24 degrees C).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8231086

Source DB:  PubMed          Journal:  Lab Anim Sci        ISSN: 0023-6764


  6 in total

1.  Pathobiochemistry of combined diabetes and atherosclerosis studied on a novel animal model. The hyperlipemic-hyperglycemic hamster.

Authors:  M Simionescu; D Popov; A Sima; M Hasu; G Costache; S Faitar; A Vulpanovici; C Stancu; D Stern; N Simionescu
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

Review 2.  Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models.

Authors:  M C Deeds; J M Anderson; A S Armstrong; D A Gastineau; H J Hiddinga; A Jahangir; N L Eberhardt; Y C Kudva
Journal:  Lab Anim       Date:  2011-04-08       Impact factor: 2.471

3.  Anomer-equilibrated streptozotocin solution for the induction of experimental diabetes in mice (Mus musculus).

Authors:  Anabel S de la Garza-Rodea; Shoshan Knaän-Shanzer; Jan D den Hartigh; Alphons P L Verhaegen; Dirk W van Bekkum
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-01       Impact factor: 1.232

4.  Novel greener approached synthesis of polyacrylic nanoparticles for therapy and care of gestational diabetes.

Authors:  Xianghong Cheng; Yahui Xu; Qian Jia; Ning Guo; Zhenzhen Wang; Yu Wang
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

5.  Protective effects of Morus alba leaves extract on ocular functions of pups from diabetic and hypercholesterolemic mother rats.

Authors:  H I H El-Sayyad; M A El-Sherbiny; M A Sobh; A M Abou-El-Naga; M A N Ibrahim; S A Mousa
Journal:  Int J Biol Sci       Date:  2011-06-04       Impact factor: 6.580

6.  Review of the mechanism of cell death resulting from streptozotocin challenge in experimental animals, its practical use and potential risk to humans.

Authors:  Chinedum Ogbonnaya Eleazu; Kate Chinedum Eleazu; Sonia Chukwuma; Udeme Nelson Essien
Journal:  J Diabetes Metab Disord       Date:  2013-12-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.